Stamos Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$7.65M |
| 2 |
CVS Health
CVS
|
+$4.27M |
| 3 |
Dominion Energy
D
|
+$2.83M |
| 4 |
American Electric Power
AEP
|
+$2.66M |
| 5 |
Southern Company
SO
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.81M |
| 2 |
Cigna
CI
|
+$1.74M |
| 3 |
Barclays
BCS
|
+$1.73M |
| 4 |
AT&T
T
|
+$1.72M |
| 5 |
TSMC
TSM
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.84% |
| 2 | Financials | 12.2% |
| 3 | Energy | 11.48% |
| 4 | Technology | 10.12% |
| 5 | Communication Services | 5.9% |
Similar funds
Stamos Capital Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Stamos Capital Partners held 139 positions worth $471M, up 7% from $441M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Stamos Capital Partners deployed $38.1M of net new capital in Q2 2024, opening 16 new positions and adding to 70 existing holdings. Its largest new stake was Dominion Energy: 55,470 shares worth $2.72M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $2.81M trimmed.
- Stamos Capital Partners's largest Q2 2024 buy was Dominion Energy: 55,470 shares worth $2.72M.
- Stamos Capital Partners added most to Walgreens Boots Alliance in Q2 2024, an estimated $7.65M increase.
- Stamos Capital Partners's biggest Q2 2024 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $2.81M.
- Stamos Capital Partners fully exited Cigna in Q2 2024, selling an estimated $1.74M.
- Stamos Capital Partners's ten largest holdings make up 42% of its $471M portfolio in Q2 2024.
- Stamos Capital Partners opened 16 new positions and closed 2 in Q2 2024.
- Stamos Capital Partners's portfolio value rose 7% quarter-over-quarter to $471M.
Based on Stamos Capital Partners's 13F filing for Q2 2024, filed 13 Aug 2024.